Affiliation:
1. Xinxiang Medical University First Affiliated Hospital
2. Xinxiang Medical University
3. King's College London Cardiovascular Division: King's College London School of Cardiovascular and Metabolic Medicine & Sciences
4. Henan University of Science and Technology Affiliated First Hospital
5. Nanyang Central Hospital
Abstract
Abstract
Epidemiological studies in recent years have identified an association between exposure to air pollutants and acute myocardial infarction (AMI); however, the association between short-term ozone (O3) exposure and AMI hospitalization remains unclear, particularly in developing countries. Therefore, this study collected information on 24,489 AMI patients, including daily air pollutant and meteorological data in Henan, China, between 2016 and 2021. A distributed lagged nonlinear model combined with a Poisson regression model was used to estimate the nonlinear lagged effect of O3 on AMI hospitalizations. We also quantified the effects of O3 on the number of AMI hospitalizations, hospitalization days, and hospitalization costs. The results showed that single- and dual-pollution models of O3 at lag0, lag1, and lag (01–07) were risk factors for AMI hospitalizations, with the most significant effect at lag03 (RR=1.132, 95% CI:1.083–1.182). Further studies showed that males, younger people (15–64 years), warm seasons, and long sunshine duration were more susceptible to O3. Hospitalizations attributable to O3 during the study period accounted for 11.66% of the total hospitalizations, corresponding to 2,856 patients, 33,492 hospital days, and 90 million RMB. Maintaining O3 at 10–130 µg/m3 can prevent hundreds of AMI hospitalizations and save millions of RMB per year in Henan, China. In conclusion, we found that short-term exposure to O3 was significantly associated with an increased risk of hospitalization for AMI in Henan, China and that further reductions in ambient O3 levels may have substantial health and economic benefits for patients and local healthcare facilities.
Publisher
Research Square Platform LLC